Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spinal muscular atrophy — insights and challenges in the treatment era
Eugenio Mercuri, Maria Carmela Pera, Mariacristina Scoto, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 12, pp. 706-715
Closed Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Adeno-associated virus as a delivery vector for gene therapy of human diseases
Jiang-Hui Wang, Dominic J. Gessler, Wei Zhan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 212
Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit
Meaghan Van Alstyne, Ivan Tattoli, Nicolas Delestrée, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 7, pp. 930-940
Open Access | Times Cited: 150
The foundation and architecture of precision medicine in neurology and psychiatry
Harald Hampel, Peng Gao, Jeffrey L. Cummings, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 3, pp. 176-198
Open Access | Times Cited: 70
Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study
Didu Kariyawasam, Arlene D’Silva, Hugo Sampaio, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 3, pp. 159-170
Closed Access | Times Cited: 45
Challenges and opportunities in spinal muscular atrophy therapeutics
Crystal Jing Jing Yeo, Eduardo F. Tizzano, Basil T. Darras
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 205-218
Closed Access | Times Cited: 21
Assessing disease progression in Spinal Muscular Atrophy, current gaps, and opportunities: a narrative review
Robert Muni‐Lofra, Giorgia Coratti, Tina Duong, et al.
Neuromuscular Disorders (2025), pp. 105341-105341
Open Access | Times Cited: 2
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 12, pp. 1110-1119
Open Access | Times Cited: 69
Large-scale neurophysiology and single-cell profiling in human neuroscience
Anthony T. Lee, Edward F. Chang, Mercedes F. Paredes, et al.
Nature (2024) Vol. 630, Iss. 8017, pp. 587-595
Closed Access | Times Cited: 14
Catecholaminergic dysfunction drives postural and locomotor deficits in a mouse model of spinal muscular atrophy
John G. Pagiazitis, Nicolas Delestrée, Leonie Sowoidnich, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115147-115147
Closed Access | Times Cited: 1
Spinal presentations in children with type 1 spinal muscular atrophy on nusinersen treatment across the SMA-REACH UK network: a retrospective national observational study
Lianne Abbott, Marion Main, Amy Wolfe, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e082240-e082240
Open Access | Times Cited: 1
Therapeutic Scoliosis-Specific Exercises for a Child With Spinal Muscular Atrophy: A Case Report
Cara Yochai, Rafael Rodriguez‐Torres, Rebekah Wallach, et al.
Pediatric Physical Therapy (2025)
Closed Access | Times Cited: 1
Setting multidisciplinary intervention goals for spinal muscular atrophy patients utilizing the international classification of functioning, disability, and health: a pilot study in a small sample sizes
Gabriele Giannotta, Marta Ruggiero, Greta Pirani, et al.
Acta Neurologica Belgica (2025)
Open Access | Times Cited: 1
Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
Marika Pane, Giorgia Coratti, Maria Carmela Pera, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 3, pp. 404-409
Open Access | Times Cited: 34
Mitochondrial Dysfunction in Spinal Muscular Atrophy
Eleonora Zilio, Valentina Piano, Brunhilde Wirth
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10878-10878
Open Access | Times Cited: 29
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 7, pp. 697-705
Closed Access | Times Cited: 29
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Tommaso Nuzzo, Rosita Russo, Francesco Errico, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 21
Respiratory morbidity in patients with spinal muscular atrophy—a changing world in the light of disease-modifying therapies
Leen Lagae, Marijke Proesmans, M. van den Hauwe, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 8
Growth hormone-releasing hormone and its analogues in health and disease
Riccarda Granata, Sheila Leone, Xianyang Zhang, et al.
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 7
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
Marika Pane, Maria Alice Donati, Costanza Cutrona, et al.
European Journal of Pediatrics (2022) Vol. 181, Iss. 7, pp. 2821-2829
Open Access | Times Cited: 26
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Neuromuscular disease genetics in under-represented populations: increasing data diversity
Lindsay A. Wilson, William L. Macken, Luke Perry, et al.
Brain (2023) Vol. 146, Iss. 12, pp. 5098-5109
Open Access | Times Cited: 15
Implantable heterogeneous triboelectric nanogenerator effectively prevents denervation-induced muscle atrophy
Shuai Zhang, Renjie Tan, Ke Zhang, et al.
Nano Energy (2024) Vol. 125, pp. 109548-109548
Closed Access | Times Cited: 6
Exploring variability in cognitive functioning in patients with spinal muscular atrophy: a scoping review
Gabriele Giannotta, Marta Ruggiero, Marta De Rinaldis, et al.
Neurological Sciences (2024) Vol. 45, Iss. 8, pp. 3699-3710
Closed Access | Times Cited: 6
Administration of adipose-derived stem cells extracellular vesicles in a murine model of spinal muscular atrophy: effects of a new potential therapeutic strategy
Federica Virla, Ermanna Turano, Ilaria Scambi, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Dysfunction of proprioceptive sensory synapses is a pathogenic event and therapeutic target in mice and humans with spinal muscular atrophy
CM Simon, Nicolas Delestrée, Jacqueline Montes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top